Evidence-Based Management of Anticoagulant Therapy¶
Holbrook, A., Schulman, S., Witt, D. M., Vandvik, P. O., Fish, J., Kovacs, M. J., Svensson, P. J., et al. (2012). Evidence-Based Management of Anticoagulant Therapy. Chest.
Cited by¶
1 citation across 1 artifact.
Each citation links to the sentence it supports in the citing article.
Domain-specific¶
- Adverse Drug Event
- The drug has a narrow therapeutic window, so patients are dosed to a target INR (International Normalized Ratio), typically about 2–3
This sourceGives the management rule the sentence states: warfarin is a narrow-therapeutic-index drug, dosed to a target INR of 2.0 to 3.0 (Grade 1B) for vitamin K antagonist therapy generally; particular indications such as mechanical mitral valve prostheses carry higher targets.
SupportedVerified against the source
- The drug has a narrow therapeutic window, so patients are dosed to a target INR (International Normalized Ratio), typically about 2–3
Verification¶
Does it exist? Confirmed. This work's DOI resolves to a registered record, which fixes its identity. That is all it fixes.
Does it back the claim? Read against the text for 1 of 1 citation: 1 supported. Each verdict is shown under its citation below, with what in the work backs the sentence.
Support is checked per citation rather than per work — the same source can be cited soundly in one article and wrongly in another. Per-citation recording began recently, so a citation with no recorded check is a gap in the record rather than evidence it went unchecked.
See how references were verified.
Registry ID ref:acb3ecebaf97 · see in the full table